Speaker illustration

Mr Aleksi Johannes Leikas

Kuopio University Hospital, Kuopio (Finland)

Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-DdNdC gene therapy: eight-year follow-up of phase 1 KAT301 study

Event: ESC Congress 2021 - The Digital Experience

Topic: Gene Therapy, Cell Therapy

Session: Basic science e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk